What we study:

Neural signaling and receptor pharmacology in normal brain functions and neurological and neuropsychiatric diseases.

Our approach:

Both mechanistic signaling studies and preclinical tests using various disease models.

Our goal:

Translate our bench-side research to improved bedside treatment.